Experimental drug reduces brain damage, eliminates brain hemorrhaging in rodents afflicted by stroke
Saturday, October 26, 2013 - 22:00
in Health & Medicine
The experimental drug 3K3A-APC shows promise as a stand-alone therapy for stroke or in combination with the FDA-approved clot-busting drug therapy tPA (tissue plasminogen activator).